{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:30:31Z","timestamp":1789648231104,"version":"4.0.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11030-023-10758-9","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:24:21Z","timestamp":1698971061000},"page":"3295-3311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular dynamics approaches"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7879-3827","authenticated-orcid":false,"given":"Thien-Vy","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-416X","authenticated-orcid":false,"given":"Vu-Thuy-Vy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Tri","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao Gia Dang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9322-8355","authenticated-orcid":false,"given":"Thanh-Thao","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-9614","authenticated-orcid":false,"given":"Khac-Minh","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"10758_CR1","unstructured":"World Health Organization (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 26 Apr 2018"},{"key":"10758_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trac.2013.04.010","volume":"50","author":"A Ga\u0142uszka","year":"2013","unstructured":"Ga\u0142uszka A, Migaszewski Z, Namie\u015bnik J (2013) The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices. TrAC Trends Anal Chem 50:78\u201384","journal-title":"TrAC Trends Anal Chem"},{"key":"10758_CR3","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","volume":"44","author":"N Masuda","year":"2000","unstructured":"Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322\u20133327. https:\/\/doi.org\/10.1128\/AAC.44.12.3322-3327.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10758_CR4","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/med.21591","volume":"39","author":"A Lamut","year":"2019","unstructured":"Lamut A, Peterlin Masic L, Kikelj D, Tomasic T (2019) Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Med Res Rev 39:2460\u20132504. https:\/\/doi.org\/10.1002\/med.21591","journal-title":"Med Res Rev"},{"key":"10758_CR5","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fmicb.2018.01144","volume":"9","author":"VK Ramaswamy","year":"2018","unstructured":"Ramaswamy VK, Vargiu AV, Malloci G, Dreier J, Ruggerone P (2018) Molecular determinants of the promiscuity of MexB and MexY multidrug transporters of Pseudomonas aeruginosa. Front Microbiol 9:1144. https:\/\/doi.org\/10.3389\/fmicb.2018.01144","journal-title":"Front Microbiol"},{"key":"10758_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/antibiotics12010180","volume":"12","author":"N Compagne","year":"2023","unstructured":"Compagne N, Vieira Da Cruz A, M\u00fcller RT, Hartkoorn RC, Flipo M, Pos KM (2023) Update on the discovery of efflux pump inhibitors against critical priority gram-negative bacteria. Antibiotics 12:180. https:\/\/doi.org\/10.3390\/antibiotics12010180","journal-title":"Antibiotics"},{"key":"10758_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4155\/fmc.15.173","volume":"8","author":"S Jamshidi","year":"2016","unstructured":"Jamshidi S, Sutton JM, Rahman KM (2016) An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors. Future Med Chem 8:195\u2013210. https:\/\/doi.org\/10.4155\/fmc.15.173","journal-title":"Future Med Chem"},{"key":"10758_CR8","doi-asserted-by":"publisher","first-page":"8506","DOI":"10.1016\/j.bmc.2006.08.037","volume":"14","author":"K Yoshida","year":"2006","unstructured":"Yoshida K, Nakayama K, Yokomizo Y, Ohtsuka M, Takemura M, Hoshino K, Kanda H, Namba K, Nitanai H, Zhang JZ et al (2006) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents. Bioorg Med Chem 14:8506\u20138518. https:\/\/doi.org\/10.1016\/j.bmc.2006.08.037","journal-title":"Bioorg Med Chem"},{"key":"10758_CR9","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.bmc.2005.10.043","volume":"14","author":"K Yoshida","year":"2006","unstructured":"Yoshida K, Nakayama K, Kuru N, Kobayashi S, Ohtsuka M, Takemura M, Hoshino K, Kanda H, Zhang JZ, Lee VJ et al (2006) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: carbon-substituted analogues at the C-2 position. Bioorg Med Chem 14:1993\u20132004. https:\/\/doi.org\/10.1016\/j.bmc.2005.10.043","journal-title":"Bioorg Med Chem"},{"key":"10758_CR10","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1016\/j.bmc.2007.07.039","volume":"15","author":"K Yoshida","year":"2007","unstructured":"Yoshida K, Nakayama K, Ohtsuka M, Kuru N, Yokomizo Y, Sakamoto A, Takemura M, Hoshino K, Kanda H, Nitanai H et al (2007) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13\u20139001, a potential preclinical candidate. Bioorg Med Chem 15:7087\u20137097. https:\/\/doi.org\/10.1016\/j.bmc.2007.07.039","journal-title":"Bioorg Med Chem"},{"key":"10758_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s0960-894x(01)00033-6","volume":"11","author":"TE Renau","year":"2001","unstructured":"Renau TE, Leger R, Flamme EM, She MW, Gannon CL, Mathias KM, Lomovskaya O, Chamberland S, Lee VJ, Ohta T et al (2001) Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 11:663\u2013667. https:\/\/doi.org\/10.1016\/s0960-894x(01)00033-6","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s0960-894x(02)00006-9","volume":"12","author":"TE Renau","year":"2002","unstructured":"Renau TE, Leger R, Yen R, She MW, Flamme EM, Sangalang J, Gannon CL, Chamberland S, Lomovskaya O, Lee VJ (2002) Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 12:763\u2013766. https:\/\/doi.org\/10.1016\/s0960-894x(02)00006-9","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR13","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/s0960-894x(03)00556-0","volume":"13","author":"TE Renau","year":"2003","unstructured":"Renau TE, Leger R, Filonova L, Flamme EM, Wang M, Yen R, Madsen D, Griffith D, Chamberland S, Dudley MN et al (2003) Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 13:2755\u20132758. https:\/\/doi.org\/10.1016\/s0960-894x(03)00556-0","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR14","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1016\/j.bmcl.2003.07.024","volume":"13","author":"K Nakayama","year":"2003","unstructured":"Nakayama K, Ishida Y, Ohtsuka M, Kawato H, Yoshida K, Yokomizo Y, Hosono S, Ohta T, Hoshino K, Ishida H et al (2003) MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization. Bioorg Med Chem Lett 13:4201\u20134204. https:\/\/doi.org\/10.1016\/j.bmcl.2003.07.024","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR15","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1016\/j.bmcl.2003.07.027","volume":"13","author":"K Nakayama","year":"2003","unstructured":"Nakayama K, Ishida Y, Ohtsuka M, Kawato H, Yoshida K, Yokomizo Y, Ohta T, Hoshino K, Otani T, Kurosaka Y et al (2003) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds. Bioorg Med Chem Lett 13:4205\u20134208. https:\/\/doi.org\/10.1016\/j.bmcl.2003.07.027","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR16","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1016\/j.bmcl.2003.07.030","volume":"13","author":"WJ Watkins","year":"2003","unstructured":"Watkins WJ, Landaverry Y, Leger R, Litman R, Renau TE, Williams N, Yen R, Zhang JZ, Chamberland S, Madsen D et al (2003) The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors. Bioorg Med Chem Lett 13:4241\u20134244. https:\/\/doi.org\/10.1016\/j.bmcl.2003.07.030","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR17","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.bmcl.2004.03.007","volume":"14","author":"K Nakayama","year":"2004","unstructured":"Nakayama K, Kuru N, Ohtsuka M, Yokomizo Y, Sakamoto A, Kawato H, Yoshida K, Ohta T, Hoshino K, Akimoto K et al (2004) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety. Bioorg Med Chem Lett 14:2493\u20132497. https:\/\/doi.org\/10.1016\/j.bmcl.2004.03.007","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bmcl.2003.10.060","volume":"14","author":"K Nakayama","year":"2004","unstructured":"Nakayama K, Kawato H, Watanabe J, Ohtsuka M, Yoshida K, Yokomizo Y, Sakamoto A, Kuru N, Ohta T, Hoshino K et al (2004) MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model. Bioorg Med Chem Lett 14:475\u2013479. https:\/\/doi.org\/10.1016\/j.bmcl.2003.10.060","journal-title":"Bioorg Med Chem Lett"},{"key":"10758_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0014-827x(01)01002-3","volume":"56","author":"MD Lee","year":"2001","unstructured":"Lee MD, Galazzo JL, Staley AL, Lee JC, Warren MS, Fuernkranz H, Chamberland S, Lomovskaya O, Miller GH (2001) Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco 56:81\u201385. https:\/\/doi.org\/10.1016\/s0014-827x(01)01002-3","journal-title":"Farmaco"},{"key":"10758_CR20","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1021\/jm9904598","volume":"42","author":"TE Renau","year":"1999","unstructured":"Renau TE, Leger R, Flamme EM, Sangalang J, She MW, Yen R, Gannon CL, Griffith D, Chamberland S, Lomovskaya O et al (1999) Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 42:4928\u20134931. https:\/\/doi.org\/10.1021\/jm9904598","journal-title":"J Med Chem"},{"key":"10758_CR21","doi-asserted-by":"publisher","first-page":"e0154490","DOI":"10.1371\/journal.pone.0154490","volume":"11","author":"D Borselli","year":"2016","unstructured":"Borselli D, Lieutaud A, Thefenne H, Garnotel E, Pages JM, Brunel JM, Bolla JM (2016) Polyamino-isoprenic derivatives block intrinsic resistance of P. aeruginosa to doxycycline and chloramphenicol in vitro. PLoS ONE 11:e0154490. https:\/\/doi.org\/10.1371\/journal.pone.0154490","journal-title":"PLoS ONE"},{"key":"10758_CR22","doi-asserted-by":"publisher","first-page":"e101840","DOI":"10.1371\/journal.pone.0101840","volume":"9","author":"V Aparna","year":"2014","unstructured":"Aparna V, Dineshkumar K, Mohanalakshmi N, Velmurugan D, Hopper W (2014) Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation. PLoS ONE 9:e101840. https:\/\/doi.org\/10.1371\/journal.pone.0101840","journal-title":"PLoS ONE"},{"key":"10758_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00044-016-1761-1","volume":"26","author":"G Mangiaterra","year":"2016","unstructured":"Mangiaterra G, Laudadio E, Cometti M, Mobbili G, Minnelli C, Massaccesi L, Citterio B, Biavasco F, Galeazzi R (2016) Inhibitors of multidrug efflux pumps of Pseudomonas aeruginosa from natural sources: an in silico high-throughput virtual screening and in vitro validation. Med Chem Res 26:414\u2013430. https:\/\/doi.org\/10.1007\/s00044-016-1761-1","journal-title":"Med Chem Res"},{"key":"10758_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.5246\/jcps.2016.04.035","volume":"25","author":"C Xiao","year":"2016","unstructured":"Xiao C (2016) KL-0153, a novel inhibitor of Pseudomonas aeruginosa MexAB-OprM efflux pump. J Chin Pharm Sci 25:310\u2013315. https:\/\/doi.org\/10.5246\/jcps.2016.04.035","journal-title":"J Chin Pharm Sci"},{"key":"10758_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.mimet.2009.09.021","volume":"79","author":"F Vidal-Aroca","year":"2009","unstructured":"Vidal-Aroca F, Meng A, Minz T, Page MG, Dreier J (2009) Use of resazurin to detect mefloquine as an efflux-pump inhibitor in Pseudomonas aeruginosa and Escherichia coli. J Microbiol Methods 79:232\u2013237. https:\/\/doi.org\/10.1016\/j.mimet.2009.09.021","journal-title":"J Microbiol Methods"},{"key":"10758_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12906-017-1913-y","volume":"17","author":"T Siriyong","year":"2017","unstructured":"Siriyong T, Srimanote P, Chusri S, Yingyongnarongkul BE, Suaisom C, Tipmanee V, Voravuthikunchai SP (2017) Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC Complement Altern Med 17:405. https:\/\/doi.org\/10.1186\/s12906-017-1913-y","journal-title":"BMC Complement Altern Med"},{"key":"10758_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-0711-10-29","volume":"10","author":"B Kouidhi","year":"2011","unstructured":"Kouidhi B, Zmantar T, Jrah H, Souiden Y, Chaieb K, Mahdouani K, Bakhrouf A (2011) Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens. Ann Clin Microbiol Antimicrob 10:29. https:\/\/doi.org\/10.1186\/1476-0711-10-29","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10758_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/antibiotics8040229","volume":"8","author":"A Reza","year":"2019","unstructured":"Reza A, Sutton JM, Rahman KM (2019) Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in gram-negative (ESKAPEE) bacteria. Antibiotics (Basel) 8:229. https:\/\/doi.org\/10.3390\/antibiotics8040229","journal-title":"Antibiotics (Basel)"},{"key":"10758_CR29","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"10758_CR30","doi-asserted-by":"publisher","first-page":"e15939","DOI":"10.1371\/journal.pone.0015939","volume":"6","author":"CY Chen","year":"2011","unstructured":"Chen CY (2011) TCM Database@Taiwan: the world\u2019s largest traditional Chinese medicine database for drug screening in silico. PLoS ONE 6:e15939. https:\/\/doi.org\/10.1371\/journal.pone.0015939","journal-title":"PLoS ONE"},{"key":"10758_CR31","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2013ligand discovery for everyone. J Chem Inf Model 55:2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"key":"10758_CR32","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1038\/s41598-019-40232-2","volume":"9","author":"K Sakurai","year":"2019","unstructured":"Sakurai K, Yamasaki S, Nakao K, Nishino K, Yamaguchi A, Nakashima R (2019) Crystal structures of multidrug efflux pump MexB bound with high-molecular-mass compounds. Sci Rep 9:4359. https:\/\/doi.org\/10.1038\/s41598-019-40232-2","journal-title":"Sci Rep"},{"key":"10758_CR33","volume-title":"Version 2022.02","author":"Molecular Operating Environment (MOE)","year":"2022","unstructured":"Molecular Operating Environment (MOE) (2022) Version 2022.02. Chemical Computing Group Inc., Montreal"},{"key":"10758_CR34","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"10758_CR35","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3390\/molecules26113115","volume":"26","author":"MT Le","year":"2021","unstructured":"Le MT, Hoang VN, Nguyen DN, Bui TH, Phan TV, Huynh PN, Tran TD, Thai KM (2021) Structure-based discovery of ABCG2 inhibitors: a homology protein-based pharmacophore modeling and molecular docking approach. Molecules 26:3115. https:\/\/doi.org\/10.3390\/molecules26113115","journal-title":"Molecules"},{"key":"10758_CR36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/50700987","volume":"5","author":"S-K Lin","year":"2000","unstructured":"Lin S-K (2000) Pharmacophore perception, development and use in drug design. Edited by Osman F. G\u00fcner. Molecules 5:987\u2013989. https:\/\/doi.org\/10.3390\/50700987","journal-title":"Molecules"},{"key":"10758_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13040-021-00244-z","volume":"14","author":"D Chicco","year":"2021","unstructured":"Chicco D, T\u00f6tsch N, Jurman G (2021) The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min 14:1\u201322. https:\/\/doi.org\/10.1186\/s13040-021-00244-z","journal-title":"BioData Min"},{"key":"10758_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11030-020-10047-9","volume":"25","author":"MT Le","year":"2021","unstructured":"Le MT, Phan TV, Tran-Nguyen VK, Tran TD, Thai KM (2021) Prediction model of human ABCC2\/MRP2 efflux pump inhibitors: a QSAR study. Mol Divers 25:741\u2013751. https:\/\/doi.org\/10.1007\/s11030-020-10047-9","journal-title":"Mol Divers"},{"key":"10758_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1573406410666140902110903","volume":"11","author":"KM Thai","year":"2015","unstructured":"Thai KM, Ngo TD, Phan TV, Tran TD, Nguyen NV, Nguyen TH, Le MT (2015) Virtual screening for novel Staphylococcus aureus NorA efflux pump inhibitors from natural products. Med Chem 11:135\u2013155. https:\/\/doi.org\/10.2174\/1573406410666140902110903","journal-title":"Med Chem"},{"key":"10758_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2175381","author":"TV Phan","year":"2023","unstructured":"Phan TV, Nguyen VT, Nguyen CH, Vu TT, Tran TD, Le MT, Trinh DT, Tran VH, Thai KM (2023) Discovery of AcrAB-TolC pump inhibitors: virtual screening and molecular dynamics simulation approach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2175381","journal-title":"J Biomol Struct Dyn"},{"key":"10758_CR41","unstructured":"Dragon for Windows(Software for MolecularDescriptor Calculations)version 5.5 (2007). TaleteSRL, Milano, Italy. http:\/\/www.tatele.mi.it. Accessed 12 May 2022"},{"key":"10758_CR42","unstructured":"Mierswa I, Klinkenberg R (2018) RapidMiner Studio version 9.1. https:\/\/rapidminer.com. Accessed 18 Feb 2022"},{"key":"10758_CR43","unstructured":"Weka version 3.8 (2016) The WEKA Workbench. https:\/\/waikato.github.io\/weka-wiki\/. Accessed 10 Feb 2022"},{"key":"10758_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","volume":"145","author":"K Roy","year":"2015","unstructured":"Roy K, Kar S, Ambure P (2015) On a simple approach for determining applicability domain of QSAR models. Chemometr Intell Lab Syst 145:22\u201329. https:\/\/doi.org\/10.1016\/j.chemolab.2015.04.013","journal-title":"Chemometr Intell Lab Syst"},{"key":"10758_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejps.2014.05.019","volume":"62","author":"K Roy","year":"2014","unstructured":"Roy K, Kar S (2014) The rm2 metrics and regression through origin approach: reliable and useful validation tools for predictive QSAR models (Commentary on \u2019Is regression through origin useful in external validation of QSAR models?\u2019). Eur J Pharm Sci 62:111\u2013114. https:\/\/doi.org\/10.1016\/j.ejps.2014.05.019","journal-title":"Eur J Pharm Sci"},{"key":"10758_CR46","unstructured":"LeadIT version 2.0.2 (2012) BioSolveIT GmbH, Nordrhein-westfalen, Germany. https:\/\/www.biosolveit.de. Accessed 10 Feb 2019"},{"key":"10758_CR47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11030-016-9688-5","volume":"20","author":"TD Ngo","year":"2016","unstructured":"Ngo TD, Tran TD, Le MT, Thai KM (2016) Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds. Mol Divers 20:945\u2013961. https:\/\/doi.org\/10.1007\/s11030-016-9688-5","journal-title":"Mol Divers"},{"key":"10758_CR48","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/1062936X.2020.1837239","volume":"31","author":"MT Le","year":"2020","unstructured":"Le MT, Mai TT, Huynh PNH, Tran TD, Thai KM, Nguyen QT (2020) Structure-based discovery of interleukin-33 inhibitors: a pharmacophore modelling, molecular docking, and molecular dynamics simulation approach. SAR QSAR Environ Res 31:883\u2013904. https:\/\/doi.org\/10.1080\/1062936X.2020.1837239","journal-title":"SAR QSAR Environ Res"},{"key":"10758_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13321-015-0100-8","volume":"7","author":"C Empereur-Mot","year":"2015","unstructured":"Empereur-Mot C, Guillemain H, Latouche A, Zagury JF, Viallon V, Montes M (2015) Predictiveness curves in virtual screening. J Cheminform 7:52. https:\/\/doi.org\/10.1186\/s13321-015-0100-8","journal-title":"J Cheminform"},{"key":"10758_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jbi.2005.02.008","volume":"38","author":"TA Lasko","year":"2005","unstructured":"Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L (2005) The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 38:404\u2013415. https:\/\/doi.org\/10.1016\/j.jbi.2005.02.008","journal-title":"J Biomed Inform"},{"key":"10758_CR51","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1021\/acs.jcim.6b00283","volume":"56","author":"C Empereur-Mot","year":"2016","unstructured":"Empereur-Mot C, Zagury JF, Montes M (2016) Screening explorer-an interactive tool for the analysis of screening results. J Chem Inf Model 56:2281\u20132286. https:\/\/doi.org\/10.1021\/acs.jcim.6b00283","journal-title":"J Chem Inf Model"},{"key":"10758_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"10758_CR53","doi-asserted-by":"publisher","unstructured":"Lindahl E, Abraham MJ, Hess B, Van Der Spoel D (2021) GROMACS 2021.4 manual (2021.4). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.4576060","DOI":"10.5281\/zenodo.4576060"},{"key":"10758_CR54","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816","journal-title":"J Comput Chem"},{"key":"10758_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-021-10359-4","author":"TT Mai","year":"2022","unstructured":"Mai TT, Nguyen PG, Le M-T, Tran T-D, Huynh PNH, Trinh D-TT, Nguyen Q-T, Thai K-M (2022) Discovery of small molecular inhibitors for interleukin-33\/ST2 protein\u2013protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-021-10359-4","journal-title":"Mol Divers"},{"issue":"33\u201338","key":"10758_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(33\u201338):27\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"10758_CR57","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Valdes-Tresanco","year":"2021","unstructured":"Valdes-Tresanco MS, Valdes-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17:6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"key":"10758_CR58","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, Hou T (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119:9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"10758_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","volume":"1084","author":"CC David","year":"2014","unstructured":"David CC, Jacobs DJ (2014) Principal component analysis: a method for determining the essential dynamics of proteins. Methods Mol Biol 1084:193\u2013226. https:\/\/doi.org\/10.1007\/978-1-62703-658-0_11","journal-title":"Methods Mol Biol"},{"key":"10758_CR60","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/pharmaceutics13122157","volume":"13","author":"A Shafie","year":"2021","unstructured":"Shafie A, Khan S, Zehra MT, Anjum F, Hasan GM, Yadav DK, Hassan MI (2021) Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations. Pharmaceutics 13:2157. https:\/\/doi.org\/10.3390\/pharmaceutics13122157","journal-title":"Pharmaceutics"},{"key":"10758_CR61","unstructured":"PyMOL version 2.0 (2017) The PyMOL molecular graphics system, Schr\u00f6dinger, LLC. https:\/\/pymol.org\/2\/. Accessed 15 Feb 2022"},{"key":"10758_CR62","first-page":"458","volume":"5","author":"V Aparna","year":"2011","unstructured":"Aparna V, Mohanalakshmi N, Hopper W (2011) Structure-based pharmacophore and virtual screening for bacterial MexB efflux pump inhibitors. Int Proc Chem Biol Environ Eng 5:458\u2013461","journal-title":"Int Proc Chem Biol Environ Eng"},{"key":"10758_CR63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.13140\/2.1.4740.6727","volume":"6","author":"V Aparna","year":"2014","unstructured":"Aparna V, Mohanalakshmi N, Dineshkumar K, Hopper W (2014) Identification of inhibitors for RND efflux pump of Pseudomonas aeruginosa using structurebased pharmacophore modeling approach. Int J Pharm Pharm Sci 6:84\u201389. https:\/\/doi.org\/10.13140\/2.1.4740.6727","journal-title":"Int J Pharm Pharm Sci"},{"key":"10758_CR64","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/cphc.202000759","volume":"21","author":"R Kumar Roy","year":"2020","unstructured":"Kumar Roy R, Patra N (2020) Configuration flipping in distal pocket of multidrug transporter MexB impacts the efflux inhibitory mechanism. ChemPhysChem 21:2516\u20132524. https:\/\/doi.org\/10.1002\/cphc.202000759","journal-title":"ChemPhysChem"},{"key":"10758_CR65","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12300","volume":"500","author":"R Nakashima","year":"2013","unstructured":"Nakashima R, Sakurai K, Yamasaki S, Hayashi K, Nagata C, Hoshino K, Onodera Y, Nishino K, Yamaguchi A (2013) Structural basis for the inhibition of bacterial multidrug exporters. Nature 500:102\u2013106. https:\/\/doi.org\/10.1038\/nature12300","journal-title":"Nature"},{"key":"10758_CR66","doi-asserted-by":"publisher","first-page":"e00496","DOI":"10.1128\/AAC.00496-20","volume":"64","author":"D Dey","year":"2020","unstructured":"Dey D, Kavanaugh LG, Conn GL (2020) Antibiotic substrate selectivity of Pseudomonas aeruginosa MexY and MexB efflux systems is determined by a goldilocks affinity. Antimicrob Agents Chemother 64:e00496. https:\/\/doi.org\/10.1128\/AAC.00496-20","journal-title":"Antimicrob Agents Chemother"},{"key":"10758_CR67","doi-asserted-by":"publisher","first-page":"16566","DOI":"10.1039\/d2cp00951j","volume":"24","author":"S Gervasoni","year":"2022","unstructured":"Gervasoni S, Malloci G, Bosin A, Vargiu AV, Zgurskaya HI, Ruggerone P (2022) Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa. Phys Chem Chem Phys 24:16566\u201316575. https:\/\/doi.org\/10.1039\/d2cp00951j","journal-title":"Phys Chem Chem Phys"},{"key":"10758_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13321-016-0174-y","volume":"8","author":"Y Djoumbou Feunang","year":"2016","unstructured":"Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E et al (2016) ClassyFire: automated chemical classification with a comprehensive, computable taxonomy. J Cheminform 8:61. https:\/\/doi.org\/10.1186\/s13321-016-0174-y","journal-title":"J Cheminform"},{"key":"10758_CR69","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jamaoncol.2022.1047","volume":"8","author":"P Heudel","year":"2022","unstructured":"Heudel P, Frenel JS, Dalban C, Bazan F, Joly F, Arnaud A, Abdeddaim C, Chevalier-Place A, Augereau P, Pautier P et al (2022) Safety and efficacy of the mTOR inhibitor, vistusertib, combined with anastrozole in patients with hormone receptor-positive recurrent or metastatic endometrial cancer: the VICTORIA multicenter, open-label, phase 1\/2 randomized clinical trial. JAMA Oncol 8:1001\u20131009. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1047","journal-title":"JAMA Oncol"},{"key":"10758_CR70","doi-asserted-by":"publisher","first-page":"19146","DOI":"10.1021\/ja307803m","volume":"134","author":"F Collu","year":"2012","unstructured":"Collu F, Vargiu AV, Dreier J, Cascella M, Ruggerone P (2012) Recognition of imipenem and meropenem by the RND-transporter MexB studied by computer simulations. J Am Chem Soc 134:19146\u201319158. https:\/\/doi.org\/10.1021\/ja307803m","journal-title":"J Am Chem Soc"},{"key":"10758_CR71","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3389\/fmicb.2019.01301","volume":"10","author":"AA De Oliveira","year":"2019","unstructured":"De Oliveira AA, Neves BJ, Silva LdC, Soares CMdA, Andrade CH, Pereira M (2019) Drug repurposing for paracoccidioidomycosis through a computational chemogenomics framework. Front Microbiol 10:1301. https:\/\/doi.org\/10.3389\/fmicb.2019.01301","journal-title":"Front Microbiol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10758-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10758-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10758-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:24:56Z","timestamp":1733131496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10758-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10758"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10758-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"4 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}